NCBI » Bookshelf » Retroviruses » Development and Applications of Retroviral Vectors » References
 
rv
Retroviruses
John M. Coffin,1 Stephen H Hughes,2 and Harold E. Varmus3
1Tufts University School of Medicine
2TABL-Basic Research Program, Frederick Cancer Research and Development Center, National Cancer Insititute
3National Institutes of Health
Cold Spring Harbor Laboratory Press0-87969-497-11997
© 1997 Cold Spring Harbor Laboratory Press
molecular biologyinfectious diseases

References

*

*

Adam M.A., Miller A.D. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 1988; 62: 3802–3806. [PubMed]
Adam M.A., Osborne W.R., Miller A.D. R-region cDNA inserts in retroviral vectors are compatible with virus replication and high-level protein synthesis from the insert. Hum. Gene Ther. 1995; 6: 1169–1176. [PubMed]
Adam M.A., Ramesh N., Miller A.D., Osborne W.R.A. Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions. J. Virol. 1991; 65: 4985–4990. [PubMed]
Adams R.M., Wang M., Steffen D., Ledley F.D. Infection by retroviral vectors outside of their host range in the presence of replication-defective adenovirus. J. Virol. 1995; 69: 1887–1894. [PubMed]
Akgun E., Ziegler M., Grez M. Determinants of retrovirus gene expression in embryonal carcinoma cells. J. Virol. 1991; 65: 382–388. [PubMed]
Akkina R.K., Walton R.M., Chen M.L., Li Q.-X., Planelles V., Chen I.S.Y. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 1996; 70: 2581–2585. [PubMed]
Armentano D., Yu S.F., Kantoff P.W., von Ruden T., Anderson W.F., Gilboa E. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 1987; 61: 1647–1650. [PubMed]
Auffray C., Lillie J.W., Korman A.J., Boss J.M., Frechin N., Guillemot F., Cooper J., Mulligan R.C., Strominger J.L. Structure and expression of HLA-DQα and -DXα genes: Interallelic alternate splicing of the HLA-DQα gene and functional splicing of the HLA-DQα gene using a retroviral vector. Immunogenetics. 1987; 26: 63–73. [PubMed]
Bahnson A.B., Dunigan J.T., Baysal B.E., Mohney T., Atchison R.W., Nimgaonkar M.T., Ball E.D., Barranger J.A. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods. 1995; 54: 131–143. [PubMed]
Banapour B., Sernatinger J., Levy J.A. The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology. 1986; 152: 268–271. [PubMed]
Bandyopadhyay P.K., Temin H.M. Expression of complete chicken thymidine kinase gene inserted in a retrovirus vector. Mol. Cell. Biol. 1984; 4: 749–754. [PubMed]
Barklis E., Mulligan R.C., Jaenisch R. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell. 1986; 47: 391–399. [PubMed]
Barsov E.V., Hughes S.H. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus. J. Virol. 1996; 70: 3922–3929. [PubMed]
Bartek J., Bartkova J., Kyprianou N., Lalani E.-N., Staskova Z., Shearer M., Chang S., Taylor-Papadimitriou J. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. 1991; 88: 3520–3524. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Bassin R.H., Tuttle N., Fischinger P.J. Rapid cell culture assay technic for murine leukaemia viruses. Nature. 1971; 229: 564–566. [PubMed]
Bates P., Young J.A., Varmus H.E. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell. 1993; 74: 1043–1051. [PubMed]
Bender M.A., Gelinas R.E., Miller A.D. A majority of mice show long-term expression of a human β-globin gene after retrovirus transfer into hematopoietic stem cells. Mol. Cell. Biol. 1989; 9: 1426–1434. [PubMed]
Bender M.A., Miller A.D., Gelinas R.E. Expression of the human β-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells. Mol. Cell. Biol. 1988; 8: 1725–1735. [PubMed]
Bender M.A., Palmer T.D., Gelinas R.E., Miller A.D. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 1987; 61: 1639–1646. [PubMed]
Berger S.A., Bernstein A. Characterization of a retrovirus shuttle vector capable of either proviral integration or extrachromosomal replication in mouse cells. Mol. Cell. Biol. 1985; 5: 305–312. [PubMed]
Besmer P., Olshevsky U., Baltimore D., Dolberg D., Fan H. Virus-like 30S RNA in mouse cells. J. Virol. 1979; 29: 1168–1176. [PubMed]
Bestwick R.K., Kozak S.L., Kabat D. Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc. Natl. Acad. Sci. 1988; 85: 5404–5408. [PubMed]
Blaese R.M., Anderson W.F., Culver K. The ADA human gene therapy clinical protocol. Hum. Gene Ther. 1990; 1: 327–362. [PubMed]
Blaese R.M., Culver K.W., Anderson W.F., Nienhuis A.W., Dunbar C., Chang L., Mullen C., Carter C., Leitman S. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Hum. Gene Ther. 1993; 4: 521–527. [PubMed]
Blaese R.M., Culver K.W., Miller A.D., Carter C.S., Fleisher T., Clerici M., Shearer G., Chang L., Chiang Y., Tolstoshev P., Greenblatt J.J., Rosenberg S.A., Klein H., Berger M., Mullen C.A., Ramsey W.J., Muul L., Morgan R.A., Anderson W.F. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science. 1995; 270: 475–480. [PubMed]
Bodine D.M., McDonagh K.T., Brandt S.J., Ney P.A., Agricola B., Byrne E., Nienhuis A.W. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc. Natl. Acad. Sci. 1990; 87: 3738–3742. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Boone L.R., Innes C.L., Glover P.L., Linney E. Development and characterization of an Fv-1 sensitive retrovirus-packaging system: Single-hit titration kinetics observed in restrictive cells. J. Virol. 1989; 63: 2592–2597. [PubMed]
Bordignon C. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID. Hum. Gene Ther. 1993; 4: 513–520. [PubMed]
Bosselman R.A., Hsu R.Y., Bruszewski J., Hu S., Martin F., Nicolson M. Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: Expression of Moloney murine leukemia virus structural genes via the metallothionein promoter. Mol. Cell. Biol. 1987; 7: 1797–1806. [PubMed]
Bosselman R.A., Hsu R.Y., Boggs T., Hu S., Bruszewski J., Ou S., Kozar L., Martin F., Green C., Jacobsen F., Nicolson M., Schultz J.A., Semon K.M., Rishell W., Stewart R.G. Germline transmission of exogenous genes in the chicken. Science. 1989; 243: 533–535. [PubMed]
Bowtell D.D., Johnson G.R., Kelso A., Cory S. Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. Mol. Biol. Med. 1987; 4: 229–250. [PubMed]
Brenner M.K., Rill D.R., Holladay M.S., Heslop H.E., Moen R.C., Buschle M., Krance R.A., Santana V.M., Anderson W.F., Ihle J.N. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet. 1993; 342: 1134–1137. [PubMed]
Brown M., McCormack M., Zinn K.G., Farrell M.P., Bikel I., Livingston D.M. A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth. J. Virol. 1986; 60: 290–293. [PubMed]
Brown P.O., Bowerman B., Varmus H.E., Bishop J.M. Correct integration of retroviral DNA in vitro. Cell. 1987; 49: 347–357. [PubMed]
Buchschacher G.L.J., Panganiban A.T. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 1992; 66: 2731–2739. [PubMed]
Burns J.C., Friedmann T., Driever W., Burrascano M., Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. 1993; 90: 8033–8037. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Carroll R., Lin J.T., Dacquel E.J., Mosca J.D., Burke D.S., Louis D.C. St. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J. Virol. 1994; 68: 6047–6051. [PubMed]
Cepko C.L., Roberts B.E., Mulligan R.C. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell. 1984; 37: 1053–1062. [PubMed]
Cepko C., Ryder E.F., Austin C.P., Walsh C., Fekete D.M. Lineage analysis using retrovirus vectors. Methods Enzymol. 1995; 254: 387–419. [PubMed]
Chen B.F., Hwang L.H., Chen D.S. Characterization of a bicistronic retroviral vector composed of the swine vesicular disease virus internal ribosome entry site. J. Virol. 1993; 67: 2142–2148. [PubMed]
Chen B.F., Hsieh C.L., Chen D.S., Hwang L.H. Improved gene expression by a U3-based retroviral vector. Biochem. Biophys. Res. Commun. 1992; 184: 330–337. [PubMed]
Chong H., Vile R.G. Replication-competent retrovirus produced by a ‘split function’ third generation amphotropic packaging cell line. Gene Ther. 1996; 3: 624–629. [PubMed]
Chu T.H., Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 1995; 69: 2659–2663. [PubMed]
Chuck A.S., Palsson B.O. Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. Hum. Gene Ther. 1996; 7: 743–750. [PubMed]
Collins S.J. Different mechanisms account for the relative resistance of KG-1 and HL-60 cell lines to retrovirus infection. J. Virol. 1988; 62: 4346–4348. [PubMed]
Cone R.D., Mulligan R.C. High-efficiency gene transfer into mammalian cells: Generation of helper-free recombinant retrovirus with broad mammalian host range. Proc. Natl. Acad. Sci. 1984; 81: 6349–6353. [PubMed]
Cone R.D., Reilly E.B., Eisen H.N., Mulligan R.C. Tissue-specific expression of functionally rearranged λ1 Ig gene through a retrovirus vector. Science. 1987a; 236: 954–957. [PubMed]
Cone R.D., Weber-Benarous A., Baorto D., Mulligan R.C. Regulated expression of a complete human β-globin gene encoded by a transmissible retrovirus vector. Mol. Cell. Biol. 1987b; 7: 887–897. [PubMed]
Cook R.F., Cook S.J., Hodgson C.P. Retrotransposon gene engineering. BioTechnology. 1991; 9: 748–751. [PubMed]
Cooper N.R., Jensen F.C., Welsh R.M. Jr., Oldstone M.B. Lysis of RNA tumor viruses by human serum: Direct antibody-independent triggering of the classical complement pathway. J. Exp. Med. 1976; 144: 970–984. [PubMed]
Cornetta K., Morgan R.A., Gillio A., Sturm S., Baltrucki L., O'Reilly R., Anderson W.F. No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. Hum. Gene Ther. 1991; 2: 215–219. [PubMed]
Cornetta K., Moen R.C., Culver K., Morgan R.A., McLachlin J.R., Sturm S., Selegue J., London W., Blaese R.M., Anderson W.F. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum. Gene Ther. 1990; 1: 15–30. [PubMed]
Cosset F.-L., Takeuchi Y., Battini J.L., Weiss R.A., Collins M.K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 1995; 69: 7430–7436. [PubMed]
Cosset F.-L., Legras C., Chebloune Y., Savatier P., Thoraval P., Thomas J.L., Samarut J., Nigon V.M., Verdier G. A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes. J. Virol. 1990; 64: 1070–1078. [PubMed]
Cosset F.-L., Ronfort C., Molina R.-M., Flamant F., Drynda A., Benchaibi M., Valsesia S., Nigon V.-M., Verdier G. Packaging cells for avian leukosis virus-based vectors with various host ranges. J. Virol. 1992; 66: 5671–5676. [PubMed]
Culver K.W., Ram Z., Wallbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992; 256: 1550–1552. [PubMed]
Cuthbert A.P., Trott D.A., Ekong R.M., Jezzard S., England N.L., Themis M., Todd C.M., Newbold R.F. Construction and characterization of a highly stable human: Rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet Cell Genet. 1995; 71: 68–76. [PubMed]
Danos O., Mulligan R.C. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. 1988; 85: 6460–6464. [PubMed]
Derse D., Martarano L. Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity. J. Virol. 1990; 64: 401–405. [PubMed]
Desiderio S.V., Wolff K.R. Rearrangement of exogenous immunoglobulin VH and DJH gene segments after retroviral transduction into immature lymphoid cell lines. J. Exp. Med. 1988; 167: 372–388. [PubMed]
Dick J.E., Magli M.C., Huszar D., Phillips R.A., Bernstein A. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell. 1985; 42: 71–79. [PubMed]
Dillon P.J., Lenz J., Rosen C.A. Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein. J. Virol. 1991; 65: 4490–4493. [PubMed]
Donahue R.E., Kessler S.W., Bodine D., McDonagh K., Dunbar C., Goodman S., Agricola B., Byrne E., Raffeld M., Moen R., Bacher J., Zsebo K.M., Nienhuis A.W. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 1992; 176: 1125–1135. [PubMed]
Dong J., Roth M.G., Hunter E. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J. Virol. 1992; 66: 7374–7382. [PubMed]
Dougherty J.P., Temin H.M. A promoterless retroviral vector indicates that there are sequences in U3 required for 3′ RNA processing. Proc. Natl. Acad. Sci. 1987; 84: 1197–1201. [PubMed]
Dougherty J.P., Temin H.M. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J. Virol. 1988; 62: 2817–2822. [PubMed]
Dougherty J.P., Wisniewski R., Yang S., Rhode B.W., Temin H.M. New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J. Virol. 1989; 63: 3209–3212. [PubMed]
Dunbar C.E., Cottler-Fox M., O'Shaughnessy J.A., Doren S., Carter C., Berenson R., Brown S., Moen R.C., Greenblatt J., Stewart F.M., Leitman S.F., Wilson W.H., Cowan K., Young N.S., Nienhuis A.W. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995; 85: 3048–3057. [PubMed]
Dzierzak E.A., Papayannopoulou T., Mulligan R.C. Lineage-specific expression of a human β-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature. 1988; 331: 35–41. [PubMed]
Emerman M., Temin H.M. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 1984; 39: 449–467. [PubMed]
Emerman M., Temin H.M. Comparison of promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res. 1986a; 14: 9381–9396. [PubMed]
Emerman M., Temin H.M. Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol. Cell. Biol. 1986b; 6: 792–800. [PubMed]
Federspiel M.J., Bates P., Young J.A., Varmus H.E., Hughes S.H. A system for tissue-specific gene targeting: Transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proc. Natl. Acad. Sci. 1994; 91: 11241–11245. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Federspiel M.J., Swing D.A., Eagleson B., Reid S.W., Hughes S.H. Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors. Proc. Natl. Acad. Sci. 1996; 93: 4931–4936. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Fekete D.M., Cepko C.L. Replication-competent retroviral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo. Mol. Cell. Biol. 1993a; 13: 2604–2613. [PubMed]
Fekete D.M., Cepko C.L. Retroviral infection coupled with tissue transplantation limits gene transfer in the chicken embryo. Proc. Natl. Acad. Sci. 1993b; 90: 2350–2354. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Feldman R.A., Vass W.C., Tambourin P.E. Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential. Oncogene Res. 1987; 1: 441–458. [PubMed]
Finer M.H., Dull T.J., Qin L., Farson D., Roberts M.R. kat: A high-efficiency retroviral transduction system for primary human T lymphocytes. Blood. 1994; 83: 43–50. [PubMed]
Flotte T.R., Afione S.A., Conrad C., McGrath S.A., Solow R., Oka H., Zeitlin P.L., Guggino W.B., Carter B.J. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. 1993; 90: 10613–10617. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Friedrich G., Soriano P. Promoter traps in embryonic stem cells: A genetic screen to identify and mutate developmental genes in mice. Genes Dev. 1991; 5: 1513–1523. [PubMed]
Friedrich G., Soriano P. Insertional mutagenesis by retroviruses and promoter traps in embryonic stem cells. Methods Enzymol. 1993; 225: 681–701. [PubMed]
Fritsch E.F., Temin H.M. Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J. Virol. 1977; 24: 461–469. [PubMed]
Galileo D.S., Gray G.E., Owens G.C., Majors J., Sanes J.R. Neurons and glia arise from a common progenitor in chicken optic tectum: Demonstration with two retroviruses and cell type-specific antibodies. Proc. Natl. Acad. Sci. 1990; 87: 458–462. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Gelinas C., Temin H.M. Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc. Natl. Acad. Sci. 1986; 83: 9211–9215. [PubMed]
Germann U.A., Chin K.-V., Pastan I., Gottesman M.M. Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene. FASEB J. 1990; 4: 1501–1507. [PubMed]
Gilboa E., Smith C. Gene therapy for infectious diseases: The AIDS model (review). Trends Genet. 1994; 10: 139–144. [PubMed]
Golden J.A., Fields-Berry S.C., Cepko C.L. Construction and characterization of a highly complex retroviral library for lineage analysis. Proc. Natl. Acad. Sci. 1995; 92: 5704–5708. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. 1992; 89: 5547–5551. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Grez M., Akgun E., Hilberg F., Ostertag W. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl. Acad. Sci. 1990; 87: 9202–9206. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Grossman M., Raper S.E., Kozarsky K., Stein E.A., Engelhardt J.F., Muller D., Lupien P.J., Wilson J.M. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat. Genet. 1994; 6: 335–341. [PubMed]
Gudkov A.V., Kazarov A.R., Thimmapaya R., Axenovich S.A., Mazo I.A., Roninson I.B. Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization. Proc. Natl. Acad. Sci. 1994; 91: 3744–3748. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Gudkov A.V., Zelnick C.R., Kazarov A.R., Thimmapaya R., Suttle D.P., Beck W.T., Roninson I.B. Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc. Natl. Acad. Sci. 1993; 90: 3231–3235. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Guild B.C., Mulligan R.C., Gros P., Housman D.E. Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proc. Natl. Acad. Sci. 1988; 85: 1595–1599. [PubMed]
Halbert C.L., Demers G.W., Galloway D.A. The E7 gene of human papilloma virus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 1991; 65: 473–478. [PubMed]
Han L., Yun J.S., Wagner T.E. Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences. Proc. Natl. Acad. Sci. 1991; 88: 4313–4317. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Han X., Kasahara N., Kan Y.W. Ligand-directed retroviral targeting of human breast cancer cells. Proc. Natl. Acad. Sci. 1995; 92: 9747–9751. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Hantzopoulos P.A., Sullenger B.A., Ungers G., Gilboa E. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. 1989; 86: 3519–3523. [PubMed]
Harel J., Rassart E., Jolicoeur P. Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus. Virology. 1981; 110: 202–207. [PubMed]
Haskell R.E., Bowen R.A. Efficient production of transgenic cattle by retroviral infection of early embryos. Mol. Reprod. Dev. 1995; 40: 386–390. [PubMed]
Hatzoglou M., Hodgson C.P., Mularo F., Hanson R.W. Efficient packaging of a specific VL30 retroelement by ψ 2 cells which produce MoMLV recombinant retroviruses. Hum. Gene Ther. 1990; 1: 385–397. [PubMed]
Hawley R.G., Covarrubias L., Hawley T., Mintz B. Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc. Natl. Acad. Sci. 1987; 84: 2406–2410. [PubMed]
Hawley T.S., Sabourin L.A., Hawley R.G. Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells. Plasmid. 1989; 22: 120–131. [PubMed]
Herman S.A., Coffin J.M. Efficient packaging of readthrough RNA in ALV: Implications for oncogene transduction. Science. 1987; 236: 845–848. [PubMed]
Hock R.A., Miller A.D. Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells. Nature. 1986; 320: 275–277. [PubMed]
Hodgson C.P., Solaiman F. Virosomes: Cationic liposomes enhance retroviral transduction. Nat. Biotechnol. 1996; 14: 339–342. [PubMed]
Hogge D.E., Humphries R.K. Gene transfer to primary normal and malignant human hemopoietic progenitors using recombinant retroviruses. Blood. 1987; 69: 611–617. [PubMed]
Hoogerbrugge P.M., Vossen J.M., von Beusechem V.W., Valerio D. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells. Hum. Gene Ther. 1992; 3: 553–558. [PubMed]
Hoshino H., Tanaka H., Miwa M., Okada H. Human T-cell leukaemia virus is not lysed by human serum. Nature. 1984; 310: 324–325. [PubMed]
Hughes S., Kosik E. Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology. 1984; 136: 89–99. [PubMed]
Hughes S.H., Greenhouse J.J., Petropoulos C.J., Sutrave P. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 1987; 61: 3004–3012. [PubMed]
Huszar D., Balling R., Kothary R., Magli M.C., Hozumi N., Rossant J., Bernstein A. Insertion of a bacterial gene into the mouse germ line using an infectious retrovirus vector. Proc. Natl. Acad. Sci. 1985; 82: 8587–8591. [PubMed]
Hwang L.H., Gilboa E. Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection. J. Virol. 1984; 50: 417–424. [PubMed]
Jahner D., Haase K., Mulligan R., Jaenisch R. Insertion of the bacterial gpt gene into the germ line of mice by retroviral infection. Proc. Natl. Acad. Sci. 1985; 82: 6927–6931. [PubMed]
Jang S.K., Pestova T.V., Hellen C.U., Witherell G.W., Wimmer E. Cap-independent translation of picornavirus RNAs: Structure and function of the internal ribosomal entry site. Enzyme. 1990; 44: 292–309. [PubMed]
Jat P.S., Cepko C.L., Mulligan R.C., Sharp P.A. Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol. Cell. Biol. 1986; 6: 1204–1217. [PubMed]
Jhappan C., Vande Woude G.F., Robins T.S. Transduction of host cellular sequences by a retroviral shuttle vector. J. Virol. 1986; 60: 750–753. [PubMed]
Jolly D.J., Esty A.C., Subramani S., Friedmann T., Verma I.M. Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene. Nucleic Acids Res. 1983; 11: 1855–1872. [PubMed]
Joly E., Oldstone M.B. Generation of a functional cDNA encoding the LdH2 class-I molecule by using a single-LTR retroviral shuttle vector. Gene. 1991; 97: 213–221. [PubMed]
Julias J.G., Hash D., Pathak V.K. E-vectors: Development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 1995; 69: 6839–6846. [PubMed]
Kaleko M., Rutter W.J., Miller A.D. Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 1990; 10: 464–473. [PubMed]
Kaplan P.L., Simon S., Cartwright C.A., Eckhart W. cDNA cloning with a retrovirus expression vector: Generation of a pp60c-src cDNA clone. J. Virol. 1987; 61: 1731–1734. [PubMed]
Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 1994; 8: 148–154. [PubMed]
Karlsson S., Papayannopoulou T., Schweiger S.G., Stamatoyannopoulos G., Nienhuis A.W. Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein. Proc. Natl. Acad. Sci. 1987; 84: 2411–2415. [PubMed]
Kasahara N., Dozy A.M., Kan Y.W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science. 1994; 266: 1373–1376. [PubMed]
Keller G., Paige C., Gilboa E., Wagner E.F. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature. 1985; 318: 149–154. [PubMed]
Kempler G., Freitag B., Berwin B., Nanassy O., Barklis E. Characterization of the Moloney murine leukemia virus stem cell-specific repressor binding site. Virology. 1993; 193: 690–699. [PubMed]
Kim T., Leibfried-Rutledge M.L., First N.L. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with gibbon ape leukemia virus envelopes. Mol. Reprod. Dev. 1993; 35: 105–113. [PubMed]
King W., Patel M.D., Lobel L.I., Goff S.P., Nguyen-Huu M.C. Insertion mutagenesis of embryonal carcinoma cells by retroviruses. Science. 1985; 228: 554–558. [PubMed]
Kitamura T., Onishi M., Kinoshita S., Shibuya A., Miyajima A., Nolan G.P. Efficient screening of retroviral cDNA expression libraries. Proc. Natl. Acad. Sci. 1995; 92: 9146–9150. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Kohn D.B., Weinberg K.I., Nolta J.A., Heiss L.N., Lenarsky C., Crooks G.M., Hanley M.E., Annett G., Brooks J.S., El-Khoureiy A., Lawrence K., Wells S., Moen R.C., Bastian J., Williams-Herman D.E., Elder M., Wara D., Bowen T., Hershfield M.S., Mullen C.A., Blaese R.M., Parkman R. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1995; 1: 1017–1023. [PubMed]
Koo H.-M., Brown A.M.C., Kaufman R.J., Prorock C.M., Ron Y., Dougherty J.P. A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA. Virology. 1992; 186: 669–675. [PubMed]
Korman A.J., Frantz J.D., Strominger J.L., Mulligan R.C. Expression of human class II major histocompatibility complex antigens using retrovirus vectors. Proc. Natl. Acad. Sci. 1987; 84: 2150–2154. [PubMed]
Kotani H., Newton P.B., Zhang S., Chiang Y.L., Otto E., Weaver L., Blaese R.M., Anderson W.F., McGarrity G.J. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 1994; 5: 19–28. [PubMed]
Kozak S.L., Kabat D. Ping-pong amplification of a retroviral vector achieves high-level gene expression: Human growth hormone production. J. Virol. 1990; 64: 3500–3508. [PubMed]
Kriegler M., Perez C.F., Hardy C., Botchan M. Transformation mediated by the SV40 T antigens: Separation of the overlapping SV40 early genes with a retroviral vector. Cell. 1984; 38: 483–491. [PubMed]
Kuehn M.R., Bradley A., Robertson E.J., Evans M.J. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature. 1987; 326: 295–298. [PubMed]
Kwok W.W., Schuening F., Stead R.B., Miller A.D. Retroviral transfer of genes into canine hemopoietic progenitor cells in culture: A model for human gene therapy. Proc. Natl. Acad. Sci. 1986; 83: 4552–4555. [PubMed]
Landau N.R., Littman D.R. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 1992; 66: 5110–5113. [PubMed]
Landau N.R., Schatz D.G., Rosa M., Baltimore D. Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol. Cell. Biol. 1987; 7: 3237–3243. [PubMed]
Laufer E., Nelson C., Johnson R., Morgan B.A. Sonic hedgehog and fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell. 1994; 79: 993–1003. [PubMed]
Lemischka I.R., Raulet D.H., Mulligan R.C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell. 1986; 45: 917–927. [PubMed]
Lewis P.F., Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 1994; 68: 510–516. [PubMed]
Lewis P., Hensel M., Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 1992; 11: 3053–3058. [PubMed]
Lewis S., Gifford A., Baltimore D. Joining of Vκ to Jκ gene segments in a retroviral vector introduced into lymphoid cells. Nature. 1984; 308: 425–428. [PubMed]
Li L., Cohen S.N. tsg101: A novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 1996; 85: 319–329. [PubMed]
Lin S., Gaiano N., Culp P., Burns J.C., Friedmann T., Yee J.K., Hopkins N. Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Science. 1994; 265: 666–669. [PubMed]
Linial M., Medeiros E., Hayward W.S. An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: Biological and biochemical characterization. Cell. 1978; 15: 1371–1381. [PubMed]
Lobel L.I., Patel M., King W., Nguyen-Huu M.C., Goff S.P. Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene. Science. 1985; 228: 329–332. [PubMed]
Lugo T.G., Handelin B., Killary A.M., Housman D.E., Fournier R.E. Isolation of microcell hybrid clones containing retroviral vector insertions into specific human chromosomes. Mol. Cell. Biol. 1987; 7: 2814–2820. [PubMed]
Lupton S.D., Brunton L.L., Kalberg V.A., Overell R.W. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 1991; 11: 3374–3378. [PubMed]
Lynch C.M., Miller A.D. Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J. Virol. 1991; 65: 3887–3890. [PubMed]
Lynch C.M., Israel D.I., Kaufman R.J., Miller A.D. Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Hum. Gene Ther. 1993; 4: 259–272. [PubMed]
Mann R., Baltimore D. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J. Virol. 1985; 54: 401–407. [PubMed]
Mann R., Mulligan R.C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 1983; 33: 153–159. [PubMed]
Marin M., Noel D., Valsesia-Wittman S., Brockly F., Etienne-Julan M., Russell S., Cosset F.L., Piechaczyk M. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J. Virol. 1996; 70: 2957–2962. [PubMed]
Markowitz D., Goff S., Bank A. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 1988a; 62: 1120–1124. [PubMed]
Markowitz D., Goff S., Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 1988b; 167: 400–406. [PubMed]
McIvor R.S. Deletion in a recombinant retroviral vector resulting from a cryptic splice donor signal in the Moloney leukemia virus envelope gene. Virology. 1990; 176: 652–655. [PubMed]
Milan D., Nicolas J.-F. Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus. J. Virol. 1991; 65: 1938–1945. [PubMed]
Miller A.D., Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 1986; 6: 2895–2902. [PubMed]
Miller A.D., Chen F.C. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J. Virol. 1996; 70: 5564–5571. [PubMed]
Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. BioTechniques. 1989; 7: 980–990. [PubMed]
Miller A.D., Law M.F., Verma I.M. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 1985; 5: 431–437. [PubMed]
Miller A.D., Trauber D.R., Buttimore C. Factors involved in production of helper virus-free retrovirus vectors. Somatic Cell Mol. Genet. 1986; 12: 175–183. [PubMed]
Miller A.D., Jolly D.J., Friedmann T., Verma I.M. A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): Gene transfer into cells obtained from humans deficient in HPRT. Proc. Natl. Acad. Sci. 1983; 80: 4709–4713. [PubMed]
Miller A.D., Bender M.A., Harris E.A.S., Kaleko M., Gelinas R.E. Design of retroviral vectors for transfer and expression of the human β-globin gene. J. Virol. 1988; 62: 4337–4345. [PubMed]
Miller A.D., Ong E.S., Rosenfeld M.G., Verma I.M., Evans R.M. Infectious and selectable retrovirus containing an inducible rat growth hormone minigene. Science. 1984; 225: 993–998. [PubMed]
Miller A.D., Garcia J.V., von Suhr N., Lynch C.M., Wilson C., Eiden M.V. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 1991; 65: 2220–2224. [PubMed]
Miller D.G., Miller A.D. Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor. J. Virol. 1992; 66: 78–84. [PubMed]
Miller D.G., Miller A.D. A family of retroviruses that use related phosphate transporters for cell entry. J. Virol. 1994; 68: 8270–8276. [PubMed]
Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 1990; 10: 4239–4242. [PubMed]
Miller J.L., Donahue R.E., Sellers S.E., Samulski R.J., Young N.S., Nienhuis A.W. Recombinant adeno-associated virus (rAAV)-mediated expression of a human γ-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. 1994; 91: 10183–10187. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Mitrani E., Coffin J., Boetker H., Doty P. Rous sarcoma virus is integrated but not expressed in chicken early embryonic cells. Proc. Natl. Acad. Sci. 1987; 84: 2781–2784. [PubMed]
Morgan B.A., Fekete D.M. Manipulating gene expression with replication-competent retroviruses. Methods Cell Biol. 1996; 51: 185–218. [PubMed]
Morgan B.A., Izpisua-Belmonte J.-C., Duboule D., Tabin C.J. Targeted misexpression of Hox-4.6 in the avian limb bud causes apparent homeotic transformations. Nature. 1992; 358: 236–239. [PubMed]
Morgan J.R., Barrandon Y., Green H., Mulligan R.C. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science. 1987; 237: 1476–1479. [PubMed]
Morgan W.C., Kaplan D.R., Pallas D.C., Roberts T.M. Recombinant retroviruses that transduce middle T antigen cDNAs derived from polyomavirus mutants: Separation of focus formation and soft-agar growth in transformation assays and correlations with kinase activities in vitro. J. Virol. 1988; 62: 3407–3414. [PubMed]
Morgenstern J.P., Land H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 1990; 18: 3587–3596. [PubMed]
Murphy A.J.M., Efstratiadis A. Cloning vectors for expression of cDNA libraries in mammalian cells. Proc. Natl. Acad. Sci. 1987; 84: 8277–8281. [PubMed]
Murphy A.J., Schimke R.T. pλ Zd39: A new type of cDNA expression vector for low background, high efficiency directional cloning. Nucleic Acids Res. 1991; 19: 3403–3408. [PubMed]
Nabel G.J., Nabel E.G., Yang Z.-Y., Fox B.A., Plautz G.E., Gao X., Huang L., Shu S., Gordon D., Chang A.E. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, lack of toxicity in humans. Proc. Natl. Acad. Sci. 1993; 90: 11307–11311. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996; 272: 263–267. [PubMed]
Neda H., Wu C.H., Wu G.Y. Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. J. Biol. Chem. 1991; 266: 14143–14146. [PubMed]
Nelson D.L., Weis J.H., Przyborski M.J., Mulligan R.C., Seidman J.G., Housman D.E. Metaphase chromosome transfer of introduced selectable markers. J. Mol. Appl. Genet. 1984; 2: 563–577. [PubMed]
Noda T., Satake M., Robins T., Ito Y. Isolation and characterization of NIH 3T3 cells expressing polyomavirus small T antigen. J. Virol. 1986; 60: 105–113. [PubMed]
Nolan G.P., Fiering S., Nicolas J.F., Herzenberg L.A. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-Δ-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. 1988; 85: 2603–2607. [PubMed]
Oldfield E.H., Ram Z., Culver K.W., Blaese R.M., DeVroom H.L., Anderson W.F. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 1993; 4: 39–69. [PubMed]
Otto E., Jones-Trower A., Vanin E.F., Stambaugh K., Mueller S.N., Anderson W.F., McGarrity G.J. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum. Gene Ther. 1994; 5: 567–575. [PubMed]
Overell R.W., Weisser K.E., Cosman D. Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells. Mol. Cell. Biol. 1988; 8: 1803–1808. [PubMed]
Page K.A., Landau N.R., Littman D.R. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 1990; 64: 5270–5276. [PubMed]
Palmer T.D., Hock R.A., Osborne W.R.A., Miller A.D. Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc. Natl. Acad. Sci. 1987; 84: 1055–1059. [PubMed]
Pastan I., Gottesman M.M., Ueda K., Lovelace E., Rutherford A.V., Willingham M.C. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. 1988; 85: 4486–4490. [PubMed]
Paul R.W., Morris D., Hess B.W., Dunn J., Overell R.W. Increased viral titer through concentration of viral harvests from retroviral packaging lines. Hum. Gene Ther. 1993; 4: 609–615. [PubMed]
Paul S.R., Yang Y.C., Donahue R.E., Goldring S., Williams D.A. Stromal cell-associated hematopoiesis: Immortalization and characterization of a primate bone marrow-derived stromal cell line. Blood. 1991; 77: 1723–1733. [PubMed]
Paulus W., Baur I., Boyce F.M., Breakefield X.O., Reeves S.A. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 1996; 70: 62–67. [PubMed]
Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. 1993; 90: 8392–8396. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Peebles P.T. An in vitro focus-induction assay for xenotropic murine leukemia virus, feline leukemia virus C, the feline–primate viruses RD-114/CCC/M-7. Virology. 1975; 67: 288–291. [PubMed]
Perez-Reyes N., Halbert C.L., Smith P.P., Benditt E.P., McDougal J.K. Immortalization of primary human smooth muscle cells. Proc. Natl. Acad. Sci. 1992; 89: 1224–1228. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Pfeifer A.M.A., Cole K.E., Smoot D.T., Weston A., Groopman J.D., Shields P.G., Vignaud J.-M., Juillerat M., Lipsky M.M., Trump B.F., Lechner J.F., Harris C.C. Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl. Acad. Sci. 1993; 90: 5123–5127. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Poznansky M., Lever A., Bergeron L., Haseltine W., Sodroski J. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 1991; 65: 532–536. [PubMed]
Price J., Turner D., Cepko C. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. 1987; 84: 156–160. [PubMed]
Purcell D.F.J., Broscius C.M., Vanin E.F., Buckler C.E., Nienhuis A.W., Martin M.A. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J. Virol. 1996; 70: 887–897. [PubMed]
Rayner J.R., Gonda T.J. A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector. Mol. Cell. Biol. 1994; 14: 880–887. [PubMed]
Reddy S.T., Stoker A.W., Bissell M.J. Expression of Rous sarcoma virus-derived retroviral vectors in the avian blastoderm: Potential as stable genetic markers. Proc. Natl. Acad. Sci. 1991a; 88: 10505–10509. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Reddy S., DeGregori J.V., von Melchner H., Ruley H.E. Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells. J. Virol. 1991b; 65: 1507–1515. [PubMed]
Reik W., Weiher H., Jaenisch R. Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: Selective cloning of proviral and flanking host sequences. Proc. Natl. Acad. Sci. 1985; 82: 1141–1145. [PubMed]
Reilly C.F. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin. J. Cell. Physiol. 1990; 142: 342–351. [PubMed]
Rein A., Schultz A. Different recombinant murine leukemia viruses use different cell surface receptors. Virology. 1984; 136: 144–152. [PubMed]
Richardson J.H., Kaye J.F., Child L.A., Lever A.M. Helper virus-free transfer of human immunodeficiency virus type 1 vectors. J. Gen. Virol. 1995; 76: 691–696. [PubMed]
Riddell S.R., Greenberg P.D., Overell R.W., Loughran T.P., Gilbert M.J., Lupton S.D., Agosti J., Scheeler S., Coombs R.W., Corey L. Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. Hum. Gene Ther. 1992; 3: 319–338. [PubMed]
Riddell S.R., Elliott M., Lewinsohn D.A., Gilbert M.J., Wilson L., Manley S.A., Lupton S.D., Overell R.W., Reynolds T.C., Corey L., Greenberg P.D. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 1996; 2: 216–223. [PubMed]
Rill D.R., Moen R.C., Buschle M., Bartholomew C., Foreman N.K., Mirro J., Krance R.A., Ihle J.N., Brenner M.K. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood. 1992; 79: 2694–2700. [PubMed]
Rill D.R., Santana V.M., Roberts W.M., Nilson T., Bowman L.C., Krance R.A., Heslop H.E., Moen R.C., Ihle J.N., Brenner M.K. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood. 1994; 84: 380–383. [PubMed]
Rizvi T.A., Panganiban A.T. Propagation of SIV vectors by genetic complementation with a heterologous env gene. AIDS Res. Hum. Retroviruses. 1992; 8: 89–95. [PubMed]
Robertson E., Bradley A., Kuehn M., Evans M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature. 1986; 323: 445–448. [PubMed]
Rodland K.D., Brown A.M., Magun B.E. Individual mouse VL30 elements transferred to rat cells by viral pseudotypes retain their responsiveness to activators of protein kinase C. Mol. Cell. Biol. 1987; 7: 2296–2298. [PubMed]
Ronfort C., Girod A., Cosset F.-L., Legras C., Nigon V.M., Chebloune Y., Verdier G. Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line. Virology. 1995; 207: 271–275. [PubMed]
Rosenberg S.A., Blaese R.M., Anderson W.F. The N2-TIL human gene transfer protocol. Hum. Gene Ther. 1990a; 1: 73–92. [PubMed]
Rosenberg S.A., Aebersold P., Cornetta K., Kasid A., Morgan R.A., Moen R., Karson E.M., Lotze M.T., Yang J.C., Topalian S.L., Merino M.J., Culver K., Miller A.D., Blaese R.M., Anderson W.F. Gene transfer into humans: Immunotherapy of patients with advanced melanoma using tumor infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 1990b; 323: 570–578. [PubMed]
Rother R.P., Fodor W.L., Springhorn J.P., Birks C.W., Setter E., Sandrin M.S., Squinto S.P., Rollins S.A. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J. Exp. Med. 1995; 182: 1345–1355. [PubMed]
Roux P., Jeanteur P., Piechaczyk M. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: Application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proc. Natl. Acad. Sci. 1989; 86: 9079–9083. [PubMed]
Russell D.W., Miller A.D. Foamy virus vectors. J. Virol. 1996; 70: 217–222. [PubMed]
Russell D.W., Berger M.S., Miller A.D. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum. Gene Ther. 1995; 5: 635–641. [PubMed]
Russell D.W., Miller A.D., Alexander I.E. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. 1994; 91: 8915–8919. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Sablitzky F., Jonsson J.I., Cohen B.L., Phillips R.A. High frequency expression of integrated proviruses derived from enhancer trap retroviruses. Cell Growth Differ. 1993; 4: 451–459. [PubMed]
Salter D.W., Smith E.J., Hughes S.H., Wright S.E., Crittenden L.B. Transgenic chickens: Insertion of retroviral genes into the chicken germ line. Virology. 1987; 157: 236–240. [PubMed]
Sancho S., Mongini T., Tanji K., Tapscott S.J., Walker W.F., Weintraub H., Miller A.D., Miranda A.F. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, fibroblasts: A new method for diagnosing Duchenne's muscular dystrophy. N. Engl. J. Med. 1993; 329: 915–920. [PubMed]
Savatier P., Bagnis C., Thoraval P., Poncet D., Belakebi M., Mallet F., Legras C., Cosset F.-L., Thomas J.-L., Chebloune Y. Generation of a helper cell line for packaging avian leukosis virus-based vectors. J. Virol. 1989; 63: 513–522. [PubMed]
Scadden D.T., Fuller B., Cunningham J.M. Human cells infected with retrovirus vectors acquire an endogenous murine provirus. J. Virol. 1990; 64: 424–427. [PubMed]
Schmidt M., Rethwilm A. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology. 1995; 210: 167–178. [PubMed]
Schuening F.G., Kawahara K., Miller A.D., To R., Goehle S., Stewart D., Mullally K., Fisher L., Graham T.C., Appelbaum F.R., Hackman R., Osborne W.R.A., Storb R. Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs. Blood. 1991; 78: 2568–2576. [PubMed]
Scolnick E.M., Vass W.C., Howk R.S., Duesberg P.H. Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus. J. Virol. 1979; 29: 964–972. [PubMed]
Shank P.R., Linial M. Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: Characterization of a deletion in the provirus. J. Virol. 1980; 36: 450–456. [PubMed]
Sherwin S.A., Rapp U.R., Benveniste R.E., Sen A., Todaro G.J. Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virus. J. Virol. 1978; 26: 257–264. [PubMed]
Shih C.C., Stoye J.P., Coffin J.M. Highly preferred targets for retrovirus integration. Cell. 1988; 53: 531–537. [PubMed]
Shimada T., Fujii H., Mitsuya H., Nienhuis A.W. Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 1991; 88: 1043–1047. [PubMed]
Shimotohno K., Temin H.M. Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell. 1981; 26: 67–77. [PubMed]
Shimotohno K., Temin H.M. Loss of intervening sequences in genomic mouse α-globin DNA inserted in an infectious retrovirus vector. Nature. 1982; 299: 265–268. [PubMed]
Somia N.V., Zoppe M., Verma I.M. Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl. Acad. Sci. 1995; 92: 7570–7574. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Sonenberg N. Poliovirus translation. Curr. Top. Microbiol. Immunol. 1990; 161: 23–47. [PubMed]
Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 1995; 23: 628–633. [PubMed]
Sorge J., Hughes S.H. Splicing of intervening sequences introduced into an infectious retroviral vector. J. Mol. Appl. Genet. 1982; 1: 547–559. [PubMed]
Sorge J., Wright D., Erdman V.D., Cutting A.E. Amphotropic retrovirus vector system for human cell gene transfer. Mol. Cell. Biol. 1984; 4: 1730–1737. [PubMed]
Soriano P., Jaenisch R. Retroviruses as probes for mammalian development: Allocation of cells to the somatic and germ cell lineages. Cell. 1986; 46: 19–29. [PubMed]
Soriano P., Cone R.D., Mulligan R.C., Jaenisch R. Tissue-specific and ectopic expression of genes introduced into transgenic mice by retroviruses. Science. 1986; 234: 1409–1413. [PubMed]
Stacey A., Mulligan R., Jaenisch R. Rescue of type I collagen-deficient phenotype by retroviral-vector-mediated transfer of human proα1(I) collagen gene into Mov-13 cells. J. Virol. 1987; 61: 2549–2554. [PubMed]
Stewart C.L., Schuetze S., Vanek M., Wagner E.F. Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J. 1987; 6: 383–388. [PubMed]
Stoeckert C.J. Jr., Metherall J.E., Yamakawa M., Eisenstadt J.M., Weissman S.M., Forget B.G. Expression of the affected A γ globin gene associated with Greek nondeletion hereditary persistence of fetal hemoglobin. Mol. Cell. Biol. 1987; 7: 2999–3003. [PubMed]
Stoker A.W., Bissell M.J. Development of avian sarcoma and leukosis virus-based vector-packaging cell lines. J. Virol. 1988; 62: 1008–1015. [PubMed]
Stuhlmann H., Jaenisch R., Mulligan R.C. Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol. Cell. Biol. 1989; 9: 100–108. [PubMed]
Swain A., Coffin J.M. Mechanism of transduction by retroviruses. Science. 1992; 255: 841–845. [PubMed]
Tabin C.J., Hoffmann J.W., Goff S.P., Weinberg R.A. Adaptation of a retrovirus as a eukaryotic vector transmitting the herpes simplex virus thymidine kinase gene. Mol. Cell. Biol. 1982; 2: 426–436. [PubMed]
Takahara Y., Hamada K., Housman D.E. A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes. J. Virol. 1992; 66: 3725–3732. [PubMed]
Takeuchi Y., Cosset F.L., Lachmann P.J., Okada H., Weiss R.A., Collins M.K. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 1994; 68: 8001–8007. [PubMed]
Tepper R.I., Mule J.J. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther. 1994; 5: 153–164. [PubMed]
Terwilliger E.F., Godin B., Sodroski J.G., Haseltine W.A. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc. Natl. Acad. Sci. 1989; 86: 3857–3861. [PubMed]
To R.Y., Booth S.C., Neiman P.E. Inhibition of retroviral replication by antisense RNA. Mol. Cell. Biol. 1986; 6: 4758–4762. [PubMed]
Trevor K., Linney E., Oshima R.G. Suppression of endo B cytokeratin by its antisense RNA inhibits the normal coexpression of endo A cytokeratin. Proc. Natl. Acad. Sci. 1987; 84: 1040–1044. [PubMed]
Turner D.L., Cepko C.L. A common progenitor for neurons and glia persists in rat retina late in development. Nature. 1987; 328: 131–136. [PubMed]
Valsesia-Wittmann S., Drynda A., Deleage G., Aumailley M., Heard J.M., Danos O., Verdier G., Cosset F.-L. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J. Virol. 1994; 68: 4609–4619. [PubMed]
van Beusechem V.W., Kukler A., Heidt P.J., Valerio D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc. Natl. Acad. Sci. 1992; 89: 7640–7644. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
van Beusechem V.W., Bart-Baumeister J.A., Bakx T.A., Kaptein L.C., Levinsky R.J., Valerio D. Gene transfer into nonhuman primate CD34+CD11b− bone marrow progenitor cells capable of repopulating lymphoid and myeloid lineages. Hum. Gene Ther. 1994; 5: 295–305. [PubMed]
Van Beveren C., Verma I.M. Homology among oncogenes. Curr. Top. Microbiol. Immunol. 1986; 123: 73–98. [PubMed]
van der Putten H., Botteri F.M., Miller A.D., Rosenfeld M.G., Fan H., Evans R.M., Verma I.M. Efficient insertion of genes into the mouse germ line via retroviral vectors. Proc. Natl. Acad. Sci. 1985; 82: 6148–6152. [PubMed]
Vanin E.F., Kaloss M., Broscius C., Nienhuis A.W. Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 1994; 68: 4241–4250. [PubMed]
Varmus H.E., Padgett T., Heasley S., Simon G., Bishop J.M. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell. 1977; 11: 307–319. [PubMed]
Vile R.G., Ali M., Hunter E., McClure M.O. Identification of a generalised packaging sequence for D-type retroviruses and generation of a D-type retroviral vector. Virology. 1992; 189: 786–791. [PubMed]
von Melchner H., Ruley H.E. Identification of cellular promoters by using a retrovirus promoter trap. J. Virol. 1989; 63: 3227–3233. [PubMed]
Warburton D., Gersen S., Yu M.T., Jackson C., Handelin B., Housman D. Monochromosomal rodent-human hybrids from microcell fusion of human lymphoblastoid cells containing an inserted dominant selectable marker. Genomics. 1990; 6: 358–366. [PubMed]
Watanabe S., Temin H.M. Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol. Cell. Biol. 1983; 3: 2241–2249. [PubMed]
Wei C.M., Gibson M., Spear P.G., Scolnick E.M. Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1. J. Virol. 1981; 39: 935–944. [PubMed]
Weiher H., Barklis E., Ostertag W., Jaenisch R. Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J. Virol. 1987; 61: 2742–2746. [PubMed]
Weintraub H. The MyoD family and myogenesis: Redundancy, networks, and thresholds (review). Cell. 1993; 75: 1241–1244. [PubMed]
Weintraub H., Tapscott S.J., Davis R.L., Thayer M.J., Adam M.A., Lassar A.B., Miller A.D. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. 1989; 86: 5434–5438. [PubMed]
Weis J.H., Nelson D.L., Przyborski M.J., Chaplin D.D., Mulligan R.C., Housman D.E., Seidman J.G. Eukaryotic chromosome transfer: Linkage of the murine major histocompatibility complex to an inserted dominant selectable marker. Proc. Natl. Acad. Sci. 1984; 81: 4879–4883. [PubMed]
Welsh R.M. Jr., Cooper N.R., Jensen F.C., Oldstone M.B. Human serum lyses RNA tumour viruses. Nature. 1975; 257: 612–614. [PubMed]
Welsh R.M. Jr., Jensen F.C., Cooper N.R., Oldstone M.B. Inactivation of lysis of oncornaviruses by human serum. Virology. 1976; 74: 432–440. [PubMed]
Whitehead I., Kirk H., Kay R. Expression cloning of oncogenes by retroviral transfer of cDNA libraries. Mol. Cell. Biol. 1995; 15: 704–710. [PubMed]
Wilson J.M., Grossman M., Raper S.E., Baker J.R., Newton R.S., Thoene J.G. Ex vivo gene therapy of familial hypercholesterolemia. Hum. Gene Ther. 1992; 3: 179–222. [PubMed]
Wilson J.M., Jefferson D.M., Chowdhury J.R., Novikoff P.M., Johnston D.E., Mulligan R.C. Retrovirus-mediated transduction of adult hepatocytes. Proc. Natl. Acad. Sci. 1988; 85: 3014–3018. [PubMed]
Wong B.Y., Chen H., Chung S.W., Wong P.M. High-efficiency identification of genes by functional analysis from a retroviral cDNA expression library. J. Virol. 1994; 68: 5523–5531. [PubMed]
Yang Y., Vanin E.F., Whitt M.A., Fornerod M., Zwart R., Schneiderman R.D., Grosveld G., Nienhuis A.W. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum. Gene Ther. 1995; 6: 1203–1213. [PubMed]
Yang Z., Korman A.J., Cooper J., Pious D., Accolla R.S., Mulligan R.C., Strominger J.L. Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors. Mol. Cell. Biol. 1987; 7: 3923–3928. [PubMed]
Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. 1994; 91: 9564–9568. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Yee J.K., Moores J.C., Jolly D.J., Wolff J.A., Respess J.G., Friedmann T. Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. 1987; 84: 5197–5201. [PubMed]
Yu M., Ojwang J., Yamada O., Hampel A., Rapapport J., Looney D., Wong-Staal F. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. 1993; 90: 6340–6344. [PubMed] [Free Full Text in PMC icon.Free Full text in PMC]
Yu S.F., von Ruden T., Kantoff P.W., Garber C., Seiberg M., Ruther U., Anderson W.F., Wagner E.F., Gilboa E. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. 1986; 83: 3194–3198. [PubMed]
Zannettino A.C., Rayner J.R., Ashman L.K., Gonda T.J., Simmons P.J. A powerful new technique for isolating genes encoding cell surface antigens using retroviral expression cloning. J. Immunol. 1996; 156: 611–620. [PubMed]
Zhang J., Temin H.M. Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science. 1993; 259: 234–238. [PubMed]
Copyright © 1997 Cold Spring Harbor Laboratory Press
Bookshelf ǀ NCBI ǀ NLM ǀ NIH
Help ǀ Contact Bookshelf
Retroviruses1997
(navigation arrows) Go to previous chapter Go to next chapter Go to top of this page Go to bottom of this page Go to Table of Contents